Parabilis Medicines, Inc. Capital Expenditures Incurred but Not yet Paid
Parabilis Medicines, Inc. (PBLS) reported Capital Expenditures Incurred but Not yet Paid of $277.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-08-13
- 2026-06-30: Capital Expenditures Incurred but Not yet Paid 6 month $277.00K.
- 2025-06-30: Capital Expenditures Incurred but Not yet Paid 6 month $30.00K.
| Period end | Capital Expenditures Incurred but Not yet Paid 6 month |
|---|---|
| 2026-06-30 | $277.00K 10-Q · filed 2026-08-13 |
| 2025-06-30 | $30.00K 10-Q · filed 2026-08-13 |